We are live on ! Find out more
Ken Griffin

Ken Griffin Citadel Advisors

AUM $875B
1-Year Est. Return 40.91%
 

Ken Griffin founded Citadel, one of the world’s largest and most successful hedge funds. Starting his trading career from his Harvard dorm room at a young age, Griffin quickly developed a keen sense for markets and built Citadel into a global powerhouse with billions in assets under management. Known for his quantitative and technology-driven strategies, Griffin has also made headlines for significant philanthropic contributions, supporting causes in education, the arts, and public institutions. Over the years, he has earned recognition as one of the preeminent figures in modern finance.

This Fund
S&P 500
This Quarter Est. Return
+5.94%
1 Year Est. Return
+40.91%
3 Year Est. Return
+115.85%
5 Year Est. Return
+132.1%
10 Year Est. Return
+518.81%
AUM
$447B
AUM Growth
+$39.1B
Cap. Flow
-$684M
Cap. Flow %
-0.15%
Top 10 Hldgs %
27.16%
Holding
15,073
New
1,965
Increased
5,545
Reduced
5,814
Closed
1,500

Top Buys

Rank Stock Value
1
T icon
AT&T
T
+$877M
2
BKNG icon
Booking.com
BKNG
+$370M
3
SPY icon
State Street SPDR S&P 500 ETF Trust
SPY
+$329M
4
BA icon
Boeing
BA
+$303M
5
WMT icon
Walmart Inc
WMT
+$291M

Top Sells

Rank Stock Value
1
MSFT icon
Microsoft
MSFT
+$544M
2
MBB icon
iShares MBS ETF
MBB
+$461M
3
NVDA icon
NVIDIA
NVDA
+$452M
4
TMUS icon
T-Mobile US
TMUS
+$426M
5
AAPL icon
Apple
AAPL
+$408M

Sector Composition

Rank Sector Weight
1 Technology 3.15%
2 Healthcare 3.06%
3 Financials 2.35%
4 Consumer Discretionary 2.28%
5 Industrials 1.93%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
BFRA
12901
DELISTED
Biofrontera AG American Depositary Shares
BFRA
$85K ﹤0.01%
13,191
-10,134
-43% -$61.8K
PHIO icon
12902
Phio Pharmaceuticals
PHIO
$12.7M
$84K ﹤0.01%
343
+128
+60% +$31.6K
NRACW
12903
DELISTED
Northern Revival Acquisition Corporation Warrant
NRACW
$84K ﹤0.01%
+98,728
New +$71.7K
AXAS
12904
CALL
DELISTED
Abraxas Petroleum Corp
AXAS
$84K ﹤0.01%
25,900
-3,800
-13% -$10K
ABEO icon
12905
Abeona Therapeutics
ABEO
$341M
$83K ﹤0.01%
2,143
-4,821
-69% -$197K
AREC icon
12906
CALL
American Resources Corp
AREC
$308M
$83K ﹤0.01%
+32,500
New +$98.2K
AXDX
12907
CALL
DELISTED
Accelerate Diagnostics
AXDX
$83K ﹤0.01%
1,030
-300
-23% -$23.9K
FENC icon
12908
CALL
Fennec Pharmaceuticals
FENC
$411M
$83K ﹤0.01%
+11,400
New +$76.1K
KOS icon
12909
PUT
Kosmos Energy
KOS
$1.51B
$83K ﹤0.01%
24,000
-8,800
-27% -$27.3K
MIND icon
12910
PUT
MIND Technology
MIND
$43M
$83K ﹤0.01%
4,290
+3,070
+252% +$68.1K
PCSA icon
12911
Processa Pharmaceuticals
PCSA
$8.15M
$83K ﹤0.01%
20
-6
-23% -$23.2K
ASXC
12912
DELISTED
Asensus Surgical, Inc.
ASXC
$83K ﹤0.01%
26,220
-2,482,798
-99% -$6.21M
WLMS
12913
DELISTED
Williams Industrial Services Group Inc.
WLMS
$83K ﹤0.01%
+14,197
New +$71.1K
ADTX
12914
DELISTED
ADITXT INC
ADTX
0
AMRX icon
12915
CALL
Amneal Pharmaceuticals
AMRX
$6.32B
$82K ﹤0.01%
16,100
+300
+2% +$1.71K
TISI icon
12916
PUT
Team
TISI
$101M
$82K ﹤0.01%
+1,230
New +$112K
TURN
12917
DELISTED
180 Degree Capital
TURN
$82K ﹤0.01%
+10,125
New +$78.3K
YCBD icon
12918
PUT
cbdMD
YCBD
$5.2M
$82K ﹤0.01%
79
+25
+46% +$29.9K
ITI
12919
PUT
DELISTED
Iteris, Inc.
ITI
$82K ﹤0.01%
+12,300
New +$82.9K
DMK
12920
CALL
DELISTED
DMK Pharmaceuticals Corporation Common Stock
DMK
$82K ﹤0.01%
1,060
-121
-10% -$7.37K
ALR
12921
DELISTED
AlerisLife Inc
ALR
$82K ﹤0.01%
14,231
-39
-0.3% -$222
STON
12922
DELISTED
StoneMor Inc.
STON
$82K ﹤0.01%
31,248
-61,651
-66% -$140K
EEIQ icon
12923
EpicQuest Education Group
EEIQ
$3.8M
$81K ﹤0.01%
+981
New +$88.6K
MBOT icon
12924
Microbot Medical
MBOT
$104M
$81K ﹤0.01%
10,194
-6,299
-38% -$47.6K
NSYS icon
12925
Nortech Systems
NSYS
$33.8M
$81K ﹤0.01%
10,181
-15,534
-60% -$102K

Similar funds

Ken Griffin's Q2 2021 Portfolio in Review

As of Q2 2021, Ken Griffin held 15,073 positions worth $447B, up 9.6% from $408B the previous quarter. Its ten largest holdings account for 27% of the portfolio.

Ken Griffin's Q2 2021 filing shows 1,965 new, 5,545 increased, 5,814 reduced and 1,500 closed positions. Its largest new stake was Coinbase: 1,010,057 shares worth $256M. The largest sale was Microsoft, an estimated $544M.

By sector, the portfolio is most concentrated in Technology at 3.2% of assets, down from 3.9% a quarter earlier, followed by Healthcare and Financials.

  • Ken Griffin's largest Q2 2021 buy was Coinbase: 1,010,057 shares worth $256M.
  • Ken Griffin added most to AT&T in Q2 2021, an estimated $877M increase.
  • Ken Griffin's biggest Q2 2021 reduction was Microsoft, cutting an estimated $544M.
  • Ken Griffin fully exited Varian Medical Systems, Inc. in Q2 2021, selling an estimated $197M.
  • Ken Griffin's ten largest holdings make up 27% of its $447B portfolio in Q2 2021.
  • Ken Griffin opened 1,965 new positions and closed 1,500 in Q2 2021.
  • Ken Griffin's portfolio value rose 9.6% quarter-over-quarter to $447B.

Based on Citadel Advisors's 13F filing for Q2 2021, filed 16 Aug 2021.